e-learning
resources
Virtual 2020
Pre-Congress Content
Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab
F. Alhadian (Leicester, United Kingdom), J. Hakeem (Leicester, United Kingdom), A. Wright (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), Y. Amrani (Leicester, United Kingdom)
Source:
Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Session:
Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Session type:
E-poster session
Number:
2290
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Alhadian (Leicester, United Kingdom), J. Hakeem (Leicester, United Kingdom), A. Wright (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), Y. Amrani (Leicester, United Kingdom). In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab. 2290
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Posaconazole in vitro action on peripheral blood mononuclear cells from sarcoidosis patients
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006
Glucocorticoid sensitivity of peripheral mononuclear cells in children with asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Peripheral mononuclear cell response to nonspecific antigenic stimulation in children with obese asthma phenotype
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
T-regulatory cells blood content in patients with asthma exacerbation
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Compartimentalized in-vitro TNF-α production of alveolar macrophages and peripheral mononuclear cells after severe trauma
Source: Eur Respir J 2001; 18: Suppl. 33, 317s
Year: 2001
T cells in peripheral blood during viral acute exacerbation of COPD
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
Analysis of cytogenetic alterations in peripheral blood lymphocytes from asthmatic patients treated with oral corticosteroids
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils
Source: Eur Respir J 2007; 30: Suppl. 51, 353s
Year: 2007
Studies on blood lymphocytes apoptosis in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
The fraction of circulating type 2 innate lymphoid cells in peripheral blood is associated with asthma severity
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Effect of BCG-PSN on Th1 and Th2 cytokine responses of peripheral blood mononuclear cells from atopic asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003
The in vitro effect of vitamin D on peripheral blood mononuclear cell cytokine expression in COPD
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Increased cytokine production by peripheral blood mononuclear cells (PBMC) and alveolar macrophages (AM) in active sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 177s
Year: 2003
Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Expression of hyperoxidized peroxiredoxins is enhanced in peripheral blood mononuclear cells of bronchial asthma patients
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
The complex role of SOCS1 expression in peripheral blood mononuclears of patients with bronchial asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept